Levofloxacina Mylan generics Italia

Levofloxacina Mylan is a generic antibiotic medication used to treat a variety of bacterial infections. The brand 'Mylan' has a long-standing history in the generic pharmaceutical industry, known for making essential medicines more accessible worldwide.

Originally, the Mylan brand was founded in the United States in 1961 by Milan Puskar and Don Panoz. Over the decades, it grew into a global powerhouse through strategic acquisitions, including the purchase of Merck KGaA's generics business and the India-based Matrix Laboratories. In 2020, Mylan underwent a transformative merger with Upjohn, which was Pfizer’s off-patent medicine division. This merger resulted in the creation of Viatris Inc., a new global healthcare company that now oversees the Mylan brand.

While this specific product is marketed for the Italian healthcare system by Mylan S.p.A. (a subsidiary of Viatris), manufacturing occurs across a global network. Viatris operates major production hubs in India, Ireland, and various parts of Europe to supply solid oral doses like these film-coated tablets to international markets.